Chen Min, Zhang Hua, Yang Rui, Wang Xinhang, Du Liqian, Yue Yuqi, Ma Xin, Zhao Fanting, Liu Yingjie, Zhou Zhongkun, Ma Yunhao, Zhang Baizhuo, Zhao Yuanchun, Jin Yan, Zhu Hongmei, Chen Peng
School of Pharmacy, Lanzhou University, No. 199 Donggang West Road, Lanzhou 730000, PR China.
Food Chem X. 2025 Jun 2;28:102600. doi: 10.1016/j.fochx.2025.102600. eCollection 2025 May.
Exopolysaccharides (EPS) from YT013 were isolated, structurally characterized and evaluated for gastrointestinal stability and prebiotic potential. YT013-EPS-1 (57.51 kDa) demonstrated superior resistance to simulated gastrointestinal digestion and maintained structural integrity relative to YT013-EPS-2 (149.3 kDa). Both EPSs exhibited significantly increased antioxidant activity after digestion relative to their undigested forms. In an mouse fecal fermentation model, YT013-EPS-1 significantly increased SCFA production and promoted beneficial bacteria such as and , while reducing potentially pathogenic genera such as and . These microbial and metabolic shifts suggest that YT013-EPS-1 influences gut microbiota and promotes microbial metabolites associated with intestinal barrier function and host metabolic regulation. Notably, YT013-EPS-1 exerted more pronounced modulatory effects on gut microbiota composition and SCFA profiles than YT013-EPS-2. Collectively, these findings highlight the potential of YT013-EPS-1 as a prebiotic ingredient for modulating gut microbiota .
从YT013中分离出胞外多糖(EPS),对其进行结构表征,并评估其胃肠道稳定性和益生元潜力。相对于YT013-EPS-2(149.3 kDa),YT013-EPS-1(57.51 kDa)对模拟胃肠道消化表现出更强的抗性,并保持结构完整性。与未消化形式相比,两种EPS消化后抗氧化活性均显著增加。在小鼠粪便发酵模型中,YT013-EPS-1显著增加短链脂肪酸(SCFA)的产生,并促进有益菌如[具体有益菌1]和[具体有益菌2]的生长,同时减少潜在致病菌如[具体致病菌1]和[具体致病菌2]。这些微生物和代谢变化表明,YT013-EPS-1影响肠道微生物群,并促进与肠道屏障功能和宿主代谢调节相关的微生物代谢产物。值得注意的是,YT013-EPS-1对肠道微生物群组成和SCFA谱的调节作用比YT013-EPS-2更为显著。总的来说,这些发现突出了YT013-EPS-1作为调节肠道微生物群的益生元成分的潜力。